New Synthetic Opioids: What Do We Know About the Mutagenicity of Brorphine and Its Analogues?

Abstract excerpt

Since 2019, a growing number of structurally diverse, non-Fentanyl-related novel synthetic opioids (NSOs) have emerged, but little is still known on the toxic profile of several of the molecules belonging to this class. Regarding long-term toxicity, few studies have investigated the genotoxic potential of NSOs, and no genotoxic data at all are available for the subclass of Brorphine-like benzimidazolone opioids....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Berberine and alkaloids research
• Share to Cannabis and Cannabinoid Research
• Share to Cholinesterase and Neurodegenerative Diseases